In in vivo models, the investigators also showed CYP4Z1 overexpression resulted in increased tumor size, weight, and vascularization, indicating a role for CYP4Z1 in breast cancer tumor growth and progression. This evidence concerns the gene CYP4Z1 and breast carcinoma.